PTPN13 inhibited hepatocellular carcinoma through inactivation of the epidermal growth factor receptor (EGFR)/extracellular signal-regulated kinase (ERK) signaling pathway [83]. This evidence concerns the gene EGFR and hepatocellular carcinoma.